Adimolol

Adimolol
Klinički podaci
Identifikatori
CAS broj	78459-19-5
ATC kod	nije dodeljen
PubChem	71227
ChemSpider	64362
UNII	B6CJY5K2ST
Hemijski podaci
Formula	C25H29N3O3
Mol. masa	419,52 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C25H29N3O3/c1-25(2,14-15-28-22-12-6-5-11-21(22)27-24(28)30)26-16-19(29)17-31-23-13-7-9-18-8-3-4-10-20(18)23/h3-13,19,26,29H,14-17H2,1-2H3,(H,27,30) ; Key: YWRIUGFSIQMHJK-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Adimolol (MEN-935) je antihipertenzivni agens koji deluje kao neselektivni antagonist α₁-, α₂-, i β-adrenergičkog receptora .^[4]

Reference[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Palluk R, Hoefke W, Gaida W, Mierau J, Bechtel WD (July 1986). „Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II”. Naunyn-Schmiedeberg's Archives of Pharmacology 333 (3): 277–83. PMID 3020439.